Wettig Thane bought FGEN
February 21, 2024 · Form 4 insider transaction
Wettig Thane bought 834,000 shares of FibroGen Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
834,000
Price
$0.00
Total value
N/A
InsiderWettig Thane
RoleOfficer, Director
CompanyFibroGen Incorporated (FGEN)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 21, 2024
Filing dateFebruary 23, 2024
Shares owned after834,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Twenty-five percent of the shares subject to the option will vest on March 1, 2025, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.